Emcure Pharmaceuticals Q3 Results
- BSE: 544210
- NSE: EMCURE
- ISIN: INE168P01015
- Sector: -
BSE
1,360.60
-17.50 (-1.27%)
-17.50 (-1.27%)Volume10.81 K
Updated: Fri 13 Jun, 2025 | 15:29:45
NSE
1,368.30-7.60 (-0.55%)
-7.60 (-0.55%)Volume5.52 L
Updated: Fri 13 Jun, 2025 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Emcure Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,962.63 | 2,001.98 | -1.97% | 1,667.64 | 17.69% |
| Selling/ General/ Admin Expenses Total | 366.93 | 355.59 | 3.19% | 332.08 | 10.50% |
| Depreciation/ Amortization | 96.81 | 96.90 | -0.09% | 84.39 | 14.71% |
| Other Operating Expenses Total | 451.23 | 476.85 | -5.37% | 420.12 | 7.41% |
| Total Operating Expense | 1,697.69 | 1,718.01 | -1.18% | 1,464.98 | 15.89% |
| Operating Income | 264.94 | 283.98 | -6.71% | 202.67 | 30.73% |
| Net Income Before Taxes | 229.92 | 273.41 | -15.91% | 170.96 | 34.49% |
| Net Income | 153.72 | 194.57 | -20.99% | 113.45 | 35.49% |
| Diluted Normalized EPS | 8.12 | 10.33 | -21.39% | 6.53 | 24.39% |